Navigation Links
VITROS® Anti-HCV Assay

ProductsVITROS® Anti-HCV Assay
Company Ortho-Clinical Diagnostics
Item VITROS® Anti-HCV Assay
Features 
  • Runs on a fully automated, random access analyzer, so results are available at any time, in any order.
  • Clinically proven to detect for hepatitis C virus in individuals with risk factors associated with HCV infection
  • Provides presumptive evidence in conjunction with other laboratory results and clinical information of individuals infected with hepatitis C virus
    • Description The VITROS Anti-HCV assay is the third diagnostic hepatitis assay approved by the U.S. Food and Drug Administration capable of being run in a random access format on the VITROS ECi Immunodiagnostic System with Intellicheck. Now the laboratory staff can run an anti-HCV test anytime with the complete menu of more than 27 assays, and provide anti-HCV test results in one hour or less.
    Info Ortho-Clinical DiagnosticsCall Ortho-Clinical Diagnostics to buy products (US and Canada only; other locations use number below) USACanada1-866-802-9580

    Customer Service: 1-800-828-6316
    Web site: http://www.orthoclinical.com

    Related medicine products :

    1. VITROS® Anti-HBs Assay
    2. Anti-HCV Test
    3. Anti-HCV Low Titer Performance Panel
    4. Uric Acid Enzymatic Assay
    5. Lithium Enzymatic Assay Kit
    6. Retinol Binding Protein EIA Vitamin Assays 030-6110 RBP Bone and Minearl Metabolism
    7. Vitamin B6 Jumbo REA Vitamin Assays, Cardiovascular 001-RK-VB6N
    8. Vitamin B6 REA Vitamin Assays, Cardiovascular 001-RK-VB6
    9. Procleix HIV-1/HCV Assay
    10. VERSANT HIV RNA 3.0 Assay (bDNA)
    11. Wampole PreVue B. Burgdorferi Antibody Detection Assay
    OptiTape - Optically Clear sealing tape for OmniUltra PCR plates. 250 sheet roll.
    Inquire
    Top cover cold rolled steel with stove enamel coated (RAL 7035 grey) Work surface polyethylene Front, back and side windows 6 mm tempered glass 3 UV lamps Internal adjustable tempered gl
    CleanBox DNA workstation with two 254nm UV lambs & 12-hr timer, 90cm (36-inch)width, single door, 115V (w/crating)
    Medicine Products:
    (Date:10/10/2008)...Coach Holly Warlick Teams Up with Legal and Medica...Ever Cancer and Careers Seminar in,Knoxville, KNO...ion of National,Breast Cancer Awareness Month, Can...e joined forces with YWCA Knoxville, The Wellness ...e Holly Warlick, University of Tennessee,women,s b...
    (Date:10/10/2008)... The Healthcare Technology Ev... , Exton, PA (PRWEB) Sept...ey Chapters of the national Healthcare Information...forces to bring regional health information techno... conference entitled The Healthcare Technology Evo...
    (Date:10/10/2008)...ston, MABoston Medical Center (BMC) has received a...l Institute on Aging (NIA) to fund the Boston Clau...BMC,s Pepper Center is one of only 11 Pepper Cente... Americans Independence Center Program was establi...enator from Florida. During his five decades of pu...
    (Date:10/10/2008)...olecular CT adds metabolic information from PET to...gnostic imaging for maximized workflow ...ICH, Germany, Oct. 10 /PRNewswire/ -- Siemens Heal...duces molecular CT, a new concept in,integrated im...d is a,practical solution for today,s shrinking he...
    Breaking Medicine News(10 mins):Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2Health News:Boston Medical Center receives $5.8m grant 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 3Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 4
    ...e denied life-changing operations unless they agre...ash-strapped hospitals say that they will not trea...hey are going to give up on smoking. Those who do ... treatment. Smokers are at a big risk of complic...
    ...ers in good health should not be discouraged from ...act a 16-year study of nearly 9,000 men in the US ... of heart attack. The studies showed that men who...its of alcohol every day on average demonstrated n...
    ...wenty-three percent of patients showed evidence of...ment in a new study measuring drug-induced liver//...medications are the most common prescription medic...ng to data from a prospective trial conducted by t...
    ...r has said that Ottawa would invest $8.4-million o...ealth strategy.// Tony Clement said that the mone...of cardiovascular disease in Canada, particularly ... plan of attack could be formulated. He said, "To...
    Other Medicine News:Health News:Smokers Warned to Give up else Face Denial of Operations 2Health News:Smokers Warned to Give up else Face Denial of Operations 3Health News:Some Prescriptions Can Lead to Chronic Drug-Induced Liver Injury 2
    (Date:10/8/2008)...ts for Spinal Cord, Other Nerve,Injuries -, PHILA...in that enables,nerve cells to communicate with ea...oping nervous system. Research into how that prote...ells may provide a basis for eventual,treatments f...ystem,including spinal cord injury., "This expan...
    (Date:10/8/2008)...-ICR as Vaccine Adjuvant, SAN DIEGO, Oct. 8 /PRNe...poration (TSX: NVN) today presented positive data ...l-like Receptor 3 agonist, Poly IC-Poly,Arginine (...yon, France.,Study results demonstrated Poly-ICR t...like Receptor 3 (TLR3) pathway. Data showed that,P...
    (Date:10/7/2008)... for detecting polyps that can be ...ct. 7 /- At the American College of,G...do (ACG 2008), renowned,gastroenterologist Douglas...tional clinical study that evaluated the efficacy ...at is designed to improve the ability,of physician...
    (Date:10/7/2008)...all/ -- CEL-SCI Corporation,(NYSE: CVM ) announce...er,Agreement (MTA) with the National Institutes of... of Dr. Francesco M. Marincola, M.D., to,investiga...roenvironment,caused by CEL-SCI,s cancer drug Mult...s Disease and Immunogentics Section, Department of...
    Breaking Medicine Technology:Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 3Mom You Rock 21 17145 1What You Dont Know Could Hurt You 17142 1What You Dont Know Could Hurt You 17142 2What You Dont Know Could Hurt You 17142 3Telik Presents Preclinical Data at 99th Annual Meeting of the American Association for Cancer Research 4690 1Telik Presents Preclinical Data at 99th Annual Meeting of the American Association for Cancer Research 4690 2Telik Presents Preclinical Data at 99th Annual Meeting of the American Association for Cancer Research 4690 3Breast Feeding While on Seizure Meds Doesnt Harm Babies 17141 1Breast Feeding While on Seizure Meds Doesnt Harm Babies 17141 2
    ...9, 2007 - Pfizer said today that,results showing p...melanoma, thyroid, liver, non-small cell lung (NSC...C) - a type of advanced kidney,cancer - will be pr...cal Oncology (ASCO) annual meeting in Chicago., "E...atment, so,it,s critical that physicians have the ...
    ...07 /PRNewswire/ -- Phase II,results exceed expecta...TM) , Australian drug development company Alchemia...d and Drug Administration (FDA),following the succ...f its metastatic colorectal cancer treatment, HyCA... II clinical trial in 80,patients with metastatic ...
    Other Medicine Technology:New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 2New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 3New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 4New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 5Positive Final Data from HyCAMP Phase II Trial in Metastatic,Colorectal 2Positive Final Data from HyCAMP Phase II Trial in Metastatic,Colorectal 3Positive Final Data from HyCAMP Phase II Trial in Metastatic,Colorectal 4